SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, has agreed to sell six prescription drugs to Swiss group Acino for R1.8bn, part of its strategy to refine its portfolio and reduce debt.
The medicines are used for the treatment of gastroenterology, erectile dysfunction and cardiovascular diseases, and generated R512m in revenue in Aspen’s 2021 year — about 1.3% of the group's...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.